The impact of atrial fibrillation on prognosis in aortic stenosis.


Journal

European heart journal. Quality of care & clinical outcomes
ISSN: 2058-1742
Titre abrégé: Eur Heart J Qual Care Clin Outcomes
Pays: England
ID NLM: 101677796

Informations de publication

Date de publication:
20 Jan 2023
Historique:
entrez: 20 1 2023
pubmed: 21 1 2023
medline: 21 1 2023
Statut: aheadofprint

Résumé

Atrial fibrillation (AF) and aortic stenosis (AS) are both highly prevalent and often coexist. Various studies have focused on the prognostic value of AF in patients with AS, but rarely considered left ventricular (LV) diastolic function as a prognostic factor. To evaluate the prognostic impact of AF in patients with AS while correcting for LV diastolic function. Patients with first diagnosis of significant AS were selected and stratified according to history of AF. The endpoint was all-cause mortality. In total, 2849 patients with significant AS (mean age 72 ± 12 years, 54.8% men) were evaluated and 686 (24.1%) had a history of AF. During a median follow-up of 60 (30 to 97) months, 1182 (41.5%) patients died. Ten-year mortality rate in patients with AF was 46.8% compared to 36.8% in patients with sinus rhythm (SR) (log-rank p<0.001). On univariable (HR: 1.42; 95% CI: 1.25 to 1.62; p<0.001) and multivariable Cox regression analysis (HR: 1.19; 95% CI: 1.02 to 1.38; p = 0.026), AF was independently associated with mortality. However, when correcting for indexed left atrial volume, E/e' or both, AF was no longer independently associated with all-cause mortality. Patients with significant AS and AF have a reduced survival as compared to patients with SR. Nonetheless, when correcting for markers of LV diastolic function, AF was not independently associated with outcomes in patients with significant AS.

Sections du résumé

BACKGROUND BACKGROUND
Atrial fibrillation (AF) and aortic stenosis (AS) are both highly prevalent and often coexist. Various studies have focused on the prognostic value of AF in patients with AS, but rarely considered left ventricular (LV) diastolic function as a prognostic factor.
OBJECTIVE OBJECTIVE
To evaluate the prognostic impact of AF in patients with AS while correcting for LV diastolic function.
METHODS METHODS
Patients with first diagnosis of significant AS were selected and stratified according to history of AF. The endpoint was all-cause mortality.
RESULTS RESULTS
In total, 2849 patients with significant AS (mean age 72 ± 12 years, 54.8% men) were evaluated and 686 (24.1%) had a history of AF. During a median follow-up of 60 (30 to 97) months, 1182 (41.5%) patients died. Ten-year mortality rate in patients with AF was 46.8% compared to 36.8% in patients with sinus rhythm (SR) (log-rank p<0.001). On univariable (HR: 1.42; 95% CI: 1.25 to 1.62; p<0.001) and multivariable Cox regression analysis (HR: 1.19; 95% CI: 1.02 to 1.38; p = 0.026), AF was independently associated with mortality. However, when correcting for indexed left atrial volume, E/e' or both, AF was no longer independently associated with all-cause mortality.
CONCLUSION CONCLUSIONS
Patients with significant AS and AF have a reduced survival as compared to patients with SR. Nonetheless, when correcting for markers of LV diastolic function, AF was not independently associated with outcomes in patients with significant AS.

Identifiants

pubmed: 36669758
pii: 6994520
doi: 10.1093/ehjqcco/qcad004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.

Auteurs

Dorien Laenens (D)

Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands.

Jan Stassen (J)

Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands.

Xavier Galloo (X)

Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands.

See Hooi Ewe (SH)

Department of Cardiology, National Heart Center Singapore, 5 Hospital Drive, Singapore 169609, Singapore, Singapore.

Gurpreet K Singh (GK)

Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands.

Mohammed R Ammanullah (MR)

Department of Cardiology, National Heart Center Singapore, 5 Hospital Drive, Singapore 169609, Singapore, Singapore.

Kensuke Hirasawa (K)

Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands.

Ching-Hui Sia (CH)

Department of Cardiology, National University Heart Center Singapore, 5 Lower Kent Ridge Rd, Singapore 119074, Singapore.

Steele C Butcher (SC)

Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands.
Department of Cardiology, Royal Perth Hospital, 197 Wellington St, Perth, WA 6000, Australia.

Nicholas W S Chew (NWS)

Department of Cardiology, National University Heart Center Singapore, 5 Lower Kent Ridge Rd, Singapore 119074, Singapore.

William K F Kong (WKF)

Department of Cardiology, National University Heart Center Singapore, 5 Lower Kent Ridge Rd, Singapore 119074, Singapore.

Kian Keong Poh (KK)

Department of Cardiology, National University Heart Center Singapore, 5 Lower Kent Ridge Rd, Singapore 119074, Singapore.

Zee P Ding (ZP)

Department of Cardiology, National Heart Center Singapore, 5 Hospital Drive, Singapore 169609, Singapore, Singapore.

Nina Ajmone Marsan (NA)

Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands.

Jeroen J Bax (JJ)

Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands.
Department of Cardiology, Turku Heart Center, University of Turku and Turku University Hospital, Kiinamyllynkatu 4-8, 20521 Turku, Finland.

Classifications MeSH